NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
For all prescribers and health professionals both in primary care and the acute sector.
Please note, Medicines Update blogs are correct at the time of publication.
All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site. Click here for an index to all previous editions. If you would like a copy of a previous edition, please contact medicines.update@ggc.scot.nhs.uk
Click here for further information on Medicines Update and recent survey results.
If you would like to contribute to Medicines Update, click here for a guide to blog writing.
Posted: March 27, 2015.
Category - Medicines Update
Tagged with - Eye
Potential patient safety concerns were raised to East Dunbartonshire prescribing group relating to patients inadvertently continuing to use corticosteroid eye drops beyond the recommended duration. A local audit of patients after catara...
Posted: March 09, 2015.
Category - Medicines Update
Tagged with - Guidelines Update
The updated NHSGGC Chronic Non-...
Posted: March 06, 2015.
Category - Medicines Update
Tagged with - Opioids Benzodiazepines
The Department for Transport has introduced a new offence of driving with certain controlled drugs (CDs) above specified limits in the blood; this legislation<...
Posted: February 23, 2015.
Category - Medicines Update
On 7 January 2015, sodium oxybate (Xyrem®) was rescheduled as a Schedule 2 Controlled Drug (CD POM). It was previously a Schedule 4 Part 1 CD. This drug is licensed for the treatment of narcolepsy with cataplexy in adult patients, but was n...
Posted: February 23, 2015.
Category - Medicines Update
Tagged with - Opioids
Posted: February 23, 2015.
Category - Medicines Update
Tagged with - Diabetes
Posted: February 23, 2015.
Category - Medicines Update
Tagged with - Respiratory
The additions to NHSGGC Formulary agreed at ADTC, 16 February 2015, included: Brimonidine gel (Mirvaso®) for the treatment of the erythema associated with rosacea. Brimonidine reduces erythema through direct cutaneous vasocon...
Posted: February 06, 2015.
Category - Medicines Update
The MHRA has published new information and strengthened warnings related to safety of medicines related to valproate (sodium valproate, valproic acid and valproate semisodium). Valproate is associated with a dose-dependen...
Posted: February 06, 2015.
Category - Medicines Update
Tagged with - Formulary Prescribing
Urinary incontinence is common; SIGN estimates that 5-9% of the Scottish population have significant problems with urinary continence. There should be a trial of lifestyle interventions and pelvic floor exercise training or blad...
Posted: February 06, 2015.
Category - Medicines Update
Tagged with - Respiratory